Alnylam Pharmaceuticals
Earnings Date & Report
Last updated:
Alnylam Pharmaceuticals’s last earnings date was on 31 Oct 2024.
Alnylam Pharmaceuticals stock Earnings report, Estimates & History
| 2020-02-06 | -2.25 | -2.47 |
|---|---|---|
| 2020-05-06 | -1.89 | -1.62 |
| 2020-08-06 | -1.79 | -1.56 |
| 2020-11-05 | -1.75 | -2.18 |
| 2021-02-11 | -1.93 | -2.09 |
| 2021-04-29 | -1.75 | -1.71 |
| 2021-08-03 | -1.57 | -1.61 |
| 2021-10-28 | -1.51 | -1.72 |
| 2022-02-10 | -1.47 | -2.16 |
| 2022-04-28 | -1.93 | -2 |
| 2022-07-28 | -1.62 | -2.29 |
| 2022-10-27 | -1.86 | -3.32 |
| 2023-02-23 | -2.13 | -1.68 |
| 2023-05-04 | -1.97 | -1.4 |
| 2023-08-03 | -1.72 | -2.21 |
| 2023-11-02 | -1.34 | 1.15 |
| 2024-02-15 | -1.2 | -1.1 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Alnylam Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 31 Oct 2024 | N/A | N/A | N/A | N/A | N/A | |
| 1 Aug 2024 | N/A | N/A | N/A | N/A | N/A | |
| 2 May 2024 | N/A | -$0.79 | N/A | 426.51M | N/A | Earnings Call Transcript |
| 15 Feb 2024 | Beat | -$1.2 | -$1.1 | 442.9M | 439.71M | Earnings Call Transcript |
| 2 Nov 2023 | Beat | -$1.34 | $1.15 | 401.03M | 750.53M | Earnings Call Transcript |
| 3 Aug 2023 | Missed | -$1.72 | -$2.21 | 350.51M | 318.75M | Earnings Call Transcript |
| 4 May 2023 | Beat | -$1.97 | -$1.4 | 312.26M | 319.29M | Earnings Call Transcript |
| 23 Feb 2023 | Beat | -$2.13 | -$1.68 | 312.21M | 335.03M | Earnings Call Transcript |
| 27 Oct 2022 | Missed | -$1.86 | -$3.32 | N/A | 264.30M | Earnings Call Transcript |
| 28 Jul 2022 | Missed | -$1.62 | -$2.29 | 220.74M | 224.81M | Earnings Call Transcript |
| 28 Apr 2022 | Missed | -$1.93 | -$2 | 194.71M | 213.25M | Earnings Call Transcript |
| 10 Feb 2022 | Missed | -$1.47 | -$2.16 | 226.41M | 258.53M | Earnings Call Transcript |
| 28 Oct 2021 | Missed | -$1.51 | -$1.72 | 219.69M | 187.63M | Earnings Call Transcript |
| 3 Aug 2021 | Missed | -$1.57 | -$1.61 | 220.55M | 220.55M | Earnings Call Transcript |
| 29 Apr 2021 | Beat | -$1.75 | -$1.71 | 169.04M | 177.56M | Earnings Call Transcript |
| 11 Feb 2021 | Missed | -$1.93 | -$2.09 | 146.7M | 163.56M | Earnings Call Transcript |
| 5 Nov 2020 | Missed | -$1.75 | -$2.18 | 95.83M | 125.85M | |
| 6 Aug 2020 | Beat | -$1.79 | -$1.56 | 115.95M | 103.96M | Earnings Call Transcript |
| 6 May 2020 | Beat | -$1.89 | -$1.62 | 116.05M | 99.47M | |
| 6 Feb 2020 | Missed | -$2.25 | -$2.47 | 64.42M | 71.68M | Earnings Call Transcript |
Alnylam Pharmaceuticals Earnings report FAQs
When is Alnylam Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Alnylam Pharmaceuticals's earnings date was on 2 Nov 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.